It is generally accepted that increased amyloidogenic processing of the amyloid precursor protein (APP), compromised amyloid beta (Abeta) degradation, and post-translational modifications of Abeta peptides contribute to the pathogenesis of Alzheimer’s disease (AD) [1,2]. The gene discussed is APP; the disease is Alzheimer disease.